Reata Pharmaceuticals Inc (NASDAQ:RETA)
| 110.00 Delayed Data As of Jan 20 |  -3.84 / -3.37%Today’s Change | 88.17 Today|||52-Week Range 257.96 | -11.02% Year-to-Date |
Latest RETA News | Press Releases
No recent news for Reata Pharmaceuticals Inc.
Today’s Trading
| Previous close | 113.84 |
| Today’s open | 114.11 |
| Day’s range | 109.93 - 115.43 |
| Volume | 26,100 |
| Average volume (3 months) | 328,565 |
| Market cap | $4.1B |
Data as of 3:59pm ET, 01/20/2021
Growth & Valuation
| Earnings growth (last year) | -228.13% |
| Earnings growth (this year) | +20.83% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -50.52% |
| P/E ratio | NM |
| Price/Sales | 234.48 |
| Price/Book | 14.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| INSMInsmed Inc | +0.80 | +2.03% |
| CCXIChemoCentryx Inc | +1.96 | +3.22% |
| APLSApellis Pharmaceutic... | -2.70 | -5.13% |
| GWPHGW Pharmaceuticals P... | -0.10 | -0.07% |
Data as of 6:43pm ET, 01/20/2021
Financials
| Next reporting date | February 26, 2021 |
| EPS forecast (this quarter) | -$2.16 |
| Annual revenue (last year) | $26.5M |
| Annual profit (last year) | -$290.2M |
| Net profit margin | -1,094.28% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Plano, Texas |
Forecasts
